scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1056/NEJMCP023065 |
P698 | PubMed publication ID | 15128897 |
P50 | author | Dwight Rouse | Q60055438 |
David W Kimberlin | Q106402075 | ||
P433 | issue | 19 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1970-1977 | |
P577 | publication date | 2004-05-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Clinical practice. Genital herpes | |
P478 | volume | 350 |
Q30350341 | Agents and strategies in development for improved management of herpes simplex virus infection and disease. |
Q93518901 | Answer: Can you identify this condition? |
Q27755387 | Approved Antiviral Drugs over the Past 50 Years |
Q35478892 | CD8+ T cell dysfunction and increase in murine gammaherpesvirus latent viral burden in the absence of 4-1BB ligand |
Q37355008 | Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases. |
Q41219745 | Comparative Evaluation of AmpliVue HSV 1+2 Assay with ELVIS Culture for Detecting Herpes Simplex Virus 1 (HSV-1) and HSV-2 in Clinical Specimens. |
Q36192705 | Diagnosis of herpes simplex virus infections of the CNS. |
Q30402908 | Does maternal HSV-2 coinfection increase mother-to-child transmission of HIV? A systematic review |
Q59131009 | Dynamics Analysis of an Epidemiological Model with Media Impact and Two Delays |
Q97646481 | Dynamics of HSV-2 infection with a therapeutic vaccine |
Q24187642 | Episodic therapy for recurrent genital herpes in non-immunocompromized adults |
Q56767916 | Evaluation of the Luminex ARIES HSV 1&2 Assay and Comparison with the FTD Neuro 9 and In-house Real-Time PCR Assays for Detecting Herpes Simplex Viruses |
Q36632255 | Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective |
Q36025675 | Future of an "Asymptomatic" T-cell Epitope-Based Therapeutic Herpes Simplex Vaccine |
Q37679534 | Genital infection with herpes simplex virus types 1 and 2 in women from natal, Brazil |
Q52657294 | Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2). |
Q36568824 | Guidance on management of asymptomatic neonates born to women with active genital herpes lesions |
Q44710578 | Herpes Simplex Virus Infection in a University Health Population: Clinical Manifestations, Epidemiology, and Implications |
Q64264586 | Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation |
Q40456116 | Intravaginal Practices and Prevalence of Sexual and Reproductive Tract Infections Among Women in Rural Malawi. |
Q93604737 | La prévention et la prise en charge des infections par le virus de l’herpès simplex |
Q37546617 | Light microscopy, culture, molecular, and serologic methods for detection of herpes simplex virus |
Q37389852 | Management of Psoriasis Herpeticum in Pregnancy: A Clinical Conundrum. |
Q35942480 | Management of neonatal herpes simplex virus infections |
Q37132010 | Multicenter Evaluation of Meridian Bioscience HSV 1&2 Molecular Assay for Detection of Herpes Simplex Virus 1 and 2 from Clinical Cutaneous and Mucocutaneous Specimens |
Q24615077 | Oral acyclovir suppression and neurodevelopment after neonatal herpes |
Q24194490 | Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients |
Q24236379 | Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients |
Q97530363 | Prevalence of Sexually Transmitted Infections and Human Immunodeficiency Virus in Transgender Persons: A Systematic Review |
Q33640117 | Prevention and management of neonatal herpes simplex virus infections |
Q59354827 | Primary Herpes Simplex Virus Infection Mimicking a Cervical Malignancy in an Immunocompetent Individual |
Q36237138 | Seroprevalence of Herpes Simplex Virus Infection in HIV Coinfected Individuals in Eastern India with Risk Factor Analysis. |
Q37105722 | Silicone-acyclovir controlled release devices suppress primary herpes simplex virus-2 and varicella zoster virus infections in vitro |
Search more.